Iterum Therapeutics (ITRM) Assets Average (2018 - 2022)
Historic Assets Average for Iterum Therapeutics (ITRM) over the last 5 years, with Q3 2022 value amounting to $74.1 million.
- Iterum Therapeutics' Assets Average fell 2749.83% to $74.1 million in Q3 2022 from the same period last year, while for Sep 2022 it was $74.1 million, marking a year-over-year decrease of 2749.83%. This contributed to the annual value of $62.2 million for FY2021, which is 11232.43% up from last year.
- As of Q3 2022, Iterum Therapeutics' Assets Average stood at $74.1 million, which was down 2749.83% from $80.4 million recorded in Q2 2022.
- In the past 5 years, Iterum Therapeutics' Assets Average ranged from a high of $131.2 million in Q3 2018 and a low of $29.0 million during Q3 2020
- In the last 5 years, Iterum Therapeutics' Assets Average had a median value of $80.2 million in 2019 and averaged $74.4 million.
- As far as peak fluctuations go, Iterum Therapeutics' Assets Average tumbled by 6428.5% in 2019, and later skyrocketed by 25279.09% in 2021.
- Quarter analysis of 5 years shows Iterum Therapeutics' Assets Average stood at $107.4 million in 2018, then plummeted by 64.28% to $38.3 million in 2019, then fell by 22.99% to $29.5 million in 2020, then skyrocketed by 221.58% to $95.0 million in 2021, then dropped by 21.95% to $74.1 million in 2022.
- Its Assets Average was $74.1 million in Q3 2022, compared to $80.4 million in Q2 2022 and $87.8 million in Q1 2022.